The effect of oxygen on the normal and the underperfused canine kidney.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J MacIntyre.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
In this study we investigated the possibility of obtaining accurate values of arterial Po(2) from specimens of capillary blood stored in glass capillary tubes and measured in an oxygen microelectrode. It has been shown that Po(2) measurements made on the Radiometer oxygen microelectrode are as accurate as those made on the macroelectrode and that the storage of blood is as satisfactory in glass capillary tubes as in glass syringes. The important feature in obtaining accurate values for arterial Po(2) is the choice of the capillary bed and its method of preparation for sampling. If the ear lobe is massaged with thurfyl nicotinate (Trafuril) it is possible to obtain values of Po(2) from the capillary blood which are in close agreement with arterial Po(2) in normal, hyperoxic, and shocked vasoconstricted patients.
The median survival of all patients with hepatic metastases from colorectal cancer referred to the Sidney Farber Cancer Institute during a five-year period was 12.5 months. Two major factors influenced survival. The first was extent of disease at presentation. The second was the histologic grade of the cancer. The median survival of patients presenting with the least disease, characterized by less than four liver nodules visible on liver scan (n = 38), normal liver size on physical examination (n = 60), normal liver function test results (n = 30), and normal performance status (n = 91), was between 18 and 24 months, regardless of treatment. The median survival of those few patients (n = 13) who had objective responses to a variety of treatments, most of whom also had minimal disease at presentation, was also 24 months. Patients whose tumors were poorly differentiated or who had abnormal performance status or weight loss of greater than 10 per cent at presentation survived only six months (median). Those with four or more liver nodules, hepatomegaly (greater than 16-cm vertical span on physical examination), or abnormal liver function test results, survived ten, eight, and 12 months (median), respectively. It is concluded that a significant group of patients survived longer than would have been predicted by earlier literature surveys after the diagnosis of colorectal cancer metastatic to the liver. It is suggested that future therapeutic trials, using survival as a measure of response of patients with liver metastases from colorectal cancer, must be prospectively controlled before selection factors can be differentiated from significant therapy effect.
Explore the source record for details and available documents.